SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950152-09-004159
Filing Date
2009-04-27
Accepted
2009-04-24 20:32:29
Documents
1
Group Members
CRANSHIRE CAPITAL, L.P.DOWNSVIEW CAPITAL, INC.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A c50874sc13dza.htm SC 13D/A 60183
  Complete submission text file 0000950152-09-004159.txt   62113
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48459 | Film No.: 09770955
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3100 DUNDEE ROAD SUITE 703 NORTHBROOK IL 60062
Business Address 3100 DUNDEE ROAD SUITE 703 NORTHBROOK IL 60062 847 562-9030
KOPIN MITCHELL P (Filed by) CIK: 0001116628 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A